Opendata, web and dolomites

PLATOSCIENCE SIGNED

Personalized Neurostimulation Approach for the Treatment of Depression

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PLATOSCIENCE project word cloud

Explore the words cloud of the PLATOSCIENCE project. It provides you a very rough idea of what is the project "PLATOSCIENCE" about.

professionals    patient    standard    nor    2005    health    until    sme    device    market    setting    falling    customized    profit    segment    relevance    worldwide    hospitals    create    stakeholders    300    clinical    start    electrodes    online    protected    2015    depressions    cloud    platocure    revenue    regulatory    50    eeg    rehabilitation    predictive    measuring    neurostimulation    medical    yielding    plug    jobs    18    individual    yields    direct    app    patent    170bn    costing    programmable    cognitive    consists    cumulative    international    analytics    world    subject    despite    qualified    efficient    gross    15    connected    validation    conventional    headset    acute    stimulation    tracked    electrophysiological    options    people    clinics    untreated    benefits    2026    25    advantage    first    commercialisation    trans    techniques    platoscience    medication    commercialization    hereafter    acknowledge    personalised    patients    competition    solutions    cranial    group    million    portable    data    ph1    introduction    tdcs    electroencephalogram    play    home    moderate    establishing    ph    depression    treatment    neuroimaging    strategy    collection    clear    severe   

Project "PLATOSCIENCE" data sheet

The following table provides information about the project.

Coordinator
PLATOSCIENCE APS 

Organization address
address: VESTERBROGADE 26
city: KOBENHAVN
postcode: 1620
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Project website https://platoscience.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-02-01   to  2019-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    PLATOSCIENCE APS DK (KOBENHAVN) coordinator 50˙000.00

Map

 Project objective

Depression currently affects more than 300 million people worldwide, that is an increase of over 18% between 2005 and 2015. Moreover, 50% of major depressions are untreated in Europe, costing about €170Bn per year. Despite subject´s relevance, there are not any efficient nor customized treatment options, these falling often within conventional solutions (e.g. cognitive techniques), medication or neurostimulation techniques that do not acknowledge an individual rehabilitation for the patient.

Platoscience has developed the world’s first plug n’ play device based on trans-cranial direct current neurostimulation (tDCS) for a personalised at-home treatment of depression. The patent-protected device, PlatoCure, consists of a portable neurostimulation headset with two programmable electrodes, easy to use and control, connected to an app to be tracked by health professionals and for cloud data collection and predictive analytics to improve individual treatment. PlatoCure also includes online neuroimaging by electroencephalogram (EEG) that enables measuring of electrophysiological data during stimulation. This yields a significant advantage of PlatoCure against competition, strengthening market introduction to become the standard treatment device for moderate to severe depression, yielding benefits for a large group of stakeholders, including patients, medical professionals, hospitals and clinics.

The SME Ph1 will be crucial for: i) establishing partnerships with relevant stakeholders on an international level in the medical segment, ii) setting up a regulatory strategy and iii) developing a clear commercialisation strategy. Hereafter, PlatoScience will be able to start SME Ph 2 focusing on the clinical validation of the device with hospitals and clinics. Until the end of 2026, we expect a cumulative revenue of €10,1 million, gross profit of €8,25 million and to create 15 qualified new jobs, within 5 years of commercialization.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PLATOSCIENCE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PLATOSCIENCE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

VINOQUANT11SUPERPLUS (2019)

A digital based system for measuring, showing and regulation of the complexe system of wine feremtation with high precision via a Bluetooth -Refractometer, a Software and a Bluetooth Thermostat

Read More  

RoboSynFarm (2019)

Robotic Synthesis Farm

Read More